Literature DB >> 31617575

Roles of microRNAs as non-invasive biomarker and therapeutic target in colorectal cancer.

Timothy Ming-Hun Wan1, Deepak Narayanan Iyer1, Lui Ng2.   

Abstract

MicroRNAs are endogenous, short non-coding RNA molecules that function as critical regulators of various biological processes. There is a strong functional evidence linking the involvement of dysregulated miRNAs to the occurrence, development and progression of colorectal cancer. Studies indicate that while overexpression of oncomiRs, and repression of tumor suppressor miRNAs tends to drive the overall tumorigenic process, the global picture of aberrant miRNA expression in colorectal cancer can classify the disease into multiple molecular phenotypes. Moreover, the expression pattern of miRNAs in colorectal cancer make them viable disease determinants as well as potential therapeutic targets. Through this review, we will summarize the importance of miRNAs in the etiology and progression of colorectal cancer. Specifically, we will explore the key role played by these RNA molecules as likely therapeutic avenues and the strategies presently available to target them. Finally, we will investigate the role of miRNAs as potential non-invasive diagnostic and prognostic biomarkers in colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31617575     DOI: 10.14670/HH-18-171

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  169 in total

Review 1.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

2.  Circulating levels of the miRNAs, miR-194, and miR-29b, as clinically useful biomarkers for colorectal cancer.

Authors:  Gholam Basati; Amirnader Emami Razavi; Iraj Pakzad; Fardin Ali Malayeri
Journal:  Tumour Biol       Date:  2015-08-29

3.  Cancer-associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse-strand expression bias to predominantly mature 3p strands through loss of 5p strand cleavage.

Authors:  M S Anglesio; Y Wang; W Yang; J Senz; A Wan; A Heravi-Moussavi; C Salamanca; S Maines-Bandiera; D G Huntsman; G B Morin
Journal:  J Pathol       Date:  2013-02       Impact factor: 7.996

4.  Complex patterns of altered MicroRNA expression during the adenoma-adenocarcinoma sequence for microsatellite-stable colorectal cancer.

Authors:  Angela N Bartley; Hui Yao; Bedia A Barkoh; Cristina Ivan; Bal M Mishra; Asif Rashid; George A Calin; Rajyalakshmi Luthra; Stanley R Hamilton
Journal:  Clin Cancer Res       Date:  2011-09-23       Impact factor: 12.531

Review 5.  miR-122--a key factor and therapeutic target in liver disease.

Authors:  Simonetta Bandiera; Sébastien Pfeffer; Thomas F Baumert; Mirjam B Zeisel
Journal:  J Hepatol       Date:  2014-10-13       Impact factor: 25.083

6.  Diagnostic microRNA markers for screening sporadic human colon cancer and active ulcerative colitis in stool and tissue.

Authors:  Farid E Ahmed; Clark D Jeffries; Paul W Vos; Gordon Flake; Gerard J Nuovo; Dennis R Sinar; Wade Naziri; Stefan P Marcuard
Journal:  Cancer Genomics Proteomics       Date:  2009 Sep-Oct       Impact factor: 4.069

7.  Role of anti-oncomirs miR-143 and -145 in human colorectal tumors.

Authors:  Y Akao; Y Nakagawa; I Hirata; A Iio; T Itoh; K Kojima; R Nakashima; Y Kitade; T Naoe
Journal:  Cancer Gene Ther       Date:  2010-01-22       Impact factor: 5.987

8.  MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer.

Authors:  I A Asangani; S A K Rasheed; D A Nikolova; J H Leupold; N H Colburn; S Post; H Allgayer
Journal:  Oncogene       Date:  2007-10-29       Impact factor: 9.867

Review 9.  MicroRNAs are novel biomarkers of colorectal cancer.

Authors:  M I Aslam; K Taylor; J H Pringle; J S Jameson
Journal:  Br J Surg       Date:  2009-07       Impact factor: 6.939

10.  Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.

Authors:  Saiyad Bastaminejad; Morovat Taherikalani; Reza Ghanbari; Akbar Akbari; Nooshin Shabab; Massoud Saidijam
Journal:  Iran Biomed J       Date:  2016-07-19
View more
  5 in total

1.  miR-3609 Decelerates the Clearance of Sorafenib in Hepatocellular Carcinoma Cells by Targeting EPAS-1 and Reducing the Activation of the Pregnane X Receptor Pathway.

Authors:  Qing-Ping Shao; Chen Wei; Jie Yang; Wen-Zhou Zhang
Journal:  Onco Targets Ther       Date:  2020-07-27       Impact factor: 4.147

2.  MicroRNA-122-5p inhibits cell proliferation, migration and invasion by targeting CCNG1 in pancreatic ductal adenocarcinoma.

Authors:  Chen Dai; Yan Zhang; Zhihua Xu; Mengxian Jin
Journal:  Cancer Cell Int       Date:  2020-03-30       Impact factor: 5.722

3.  High Levels of Tumor miR-187-3p-A Potential Tumor-Suppressor microRNA-Are Correlated with Poor Prognosis in Colorectal Cancer.

Authors:  Lui Ng; Timothy Ming-Hun Wan; Deepak Narayanan Iyer; Zheng Huang; Ryan Wai-Yan Sin; Abraham Tak-Ka Man; Xue Li; Dominic Chi-Chung Foo; Oswens Siu-Hung Lo; Wai-Lun Law
Journal:  Cells       Date:  2022-08-05       Impact factor: 7.666

Review 4.  Emerging Challenges of Radiation-Associated Cardiovascular Dysfunction (RACVD) in Modern Radiation Oncology: Clinical Practice, Bench Investigation, and Multidisciplinary Care.

Authors:  Moon-Sing Lee; Dai-Wei Liu; Shih-Kai Hung; Chih-Chia Yu; Chen-Lin Chi; Wen-Yen Chiou; Liang-Cheng Chen; Ru-Inn Lin; Li-Wen Huang; Chia-Hui Chew; Feng-Chun Hsu; Michael W Y Chan; Hon-Yi Lin
Journal:  Front Cardiovasc Med       Date:  2020-02-21

5.  MicroRNA‑744‑5p is downregulated in colorectal cancer and targets SEPT2 to suppress the malignant phenotype.

Authors:  Wei Zhang; Kai Liao; Dongning Liu
Journal:  Mol Med Rep       Date:  2020-11-17       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.